ArticleCancer gene therapy2021

DNA-based delivery of anti-DR5 Nanobodies improves exposure and anti-tumor efficacy over protein-based administration.

Giles Vermeire et al.PubMed ↗Publisher ↗

No numbers read from the abstract.